Predicting outcome to chemotherapy in patients with germ cell tumors: The value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy Academic Article uri icon

Overview

MeSH Major

  • Biomarkers, Tumor
  • Chorionic Gonadotropin
  • Germinoma
  • Mediastinal Neoplasms
  • Retroperitoneal Neoplasms
  • Testicular Neoplasms
  • alpha-Fetoproteins

abstract

  • The rate of marker decline during chemotherapy has prognostic value independent of risk and may play a significant role in the management of poor-risk patients. It is appropriate to include patients whose markers normalized early.

publication date

  • May 2001

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 11331333

Additional Document Info

start page

  • 2534

end page

  • 41

volume

  • 19

number

  • 9